Elon Musk’s FOUR(!) Covid Tests

On Friday, Elon Musk took to Twitter, saying he was being tested for COVID-19 after experiencing mild cold symptoms.

Here’s what he had to say about the process…

elon musk tweet

In Musk’s case, Becton Dickinson’s rapid novel coronavirus test was far from accurate… and Musk was excoriated on Twitter for saying so.

Mostly, people accused him of spreading misinformation, discouraging people from getting tested and for carping like a Karen. Sheesh.

Musk says he “most likely” has COVID-19, but he’s awaiting results from the more accurate PCR test.

Personally, I think Musk’s tweets are a set up for a more significant revelation…

Send your opinions to, TheRundownFeedback@SevenFigurePublishing.com.

Your Rundown for Wednesday, Nov. 18, 2020…

A Visionary’s Pandemic Patent

Believe what you will about Elon Musk.

The 49-year old Wharton School graduate — and PhD program dropout — has disrupted eight major industries, including the space, automotive and AI sectors.

Then there’s this…


Musk’s also an innovator in the healthcare space. His company Neuralink, for example, is developing medical applications for neurological disorders — even paralysis.

Now Musk’s team of engineers and neuroscientists are working on a more pressing problem: the coronavirus pandemic. Namely, a COVID-19 vaccine.

In September, “Musk quietly visited the headquarters of German biotech firm CureVac,” says Observer Media. “The visit was to discuss collaboration between CureVac and [Tesla acquisition] Grohmann Automation… about building RNA microfactories.”

It’s almost as if Musk predicted the present-day pandemic. In 2018, Musk and CureVac, filed an international patent that says: “An acceleration of RNA manufacturing would be highly advantageous and of major importance for public health, especially in the context of pandemic scenarios.” (Emphasis ours)

CureVac is in pursuit of a RNA-based vaccine — close on the heels of Moderna, in fact — but with “RNA microfactories,” Musk expects to help CureVac and other companies manufacture vaccines and much more.

And we believe while Musk’s cadre of smart people are trying to crack the COVID-19 code (literally), they’ll also make progress on a faster, more accurate test.

For investors? Mainstreet is restricted from investing in private company Neuralink, but Tesla’s open for business. And with news that Tesla will be listed on the S&P 500 Index on Dec. 21, the future’s promising. Pandemic be damned.

Market Rundown for Wednesday, Nov. 18, 2020

S&P 500 futures are up 6.5 points to 3,613.

Oil’s up almost 1.5% to $42.04 for a barrel of West Texas crude.

Gold is down $9.10 per ounce to $1,876.

Bitcoin’s up $119.25 to $17,903.65.

Send your comments and questions to, TheRundownFeedback@SevenFigurePublishing.com.

We’ll have more to say Friday. Check back then…

For the Rundown,

Aaron Gentzler

Aaron Gentzler

You May Also Be Interested In:

Mining for Gold in Space

Asteroid mining sounds like something straight out of science fiction. But with robots getting smarter and space travel becoming more and more common in the private industry... Asteroid mining could potentially become a reality sooner rather than later.

Aaron Gentzler

Aaron Gentzler is the publisher of Seven Figure Publishing. He is also the editor of The Rundown and has been with Agora Financial / Seven Figure Publishing since 2005. He's been covering technology and markets for over a decade.

View More By Aaron Gentzler